Often called the “primary immune response assessment,” the Immunoglobulin-M (IgM) test quantifies the amount of IgM antibodies in the blood. The first antibody to be created in response to an infection is called IgM, and it is essential to the early phases of immunological defense. Because of its exceptional ability to form pathogen-eliminating complexes, this specific type of antibody is a crucial marker of recent exposure to bacteria and viruses.
Its wider significance for cardiovascular health is shown by the inclusion of “health heart diagnostics” (HHD) in the description of the basic immune response evaluation. Although IgM’s primary role is in the immune system’s reaction to novel infections, its involvement may also indirectly affect cardiovascular health. For example, many acute bacterial and viral infections indicated by increased IgM levels can result in